Clinical monitoring plays an important role in protecting trial participants, maintaining data quality and ensuring studies are conducted in accordance with their protocols and regulatory requirements.
Throughout a clinical trial, monitoring teams are responsible for reviewing site activities, identifying potential issues and ensuring findings are addressed appropriately. This helps sponsors maintain oversight of how their studies are being conducted, whether at a single research site or across multiple locations.
The importance of effective monitoring is reflected in regulatory inspection findings. The European Medicines Agency’s 2024 Good Clinical Practice inspection report recorded 35 major findings relating to clinical trial monitoring across 67 inspections requested as part of the EU centralised procedure. These findings concerned monitoring practices generally, rather than the independence of monitoring teams, and included issues with monitoring visits, documentation and the identification and escalation of findings.
While monitoring is a standard part of clinical research, maintaining its independence from site operations can provide additional assurance. This is particularly relevant when a contract research organisation (CRO) provides both site management and clinical monitoring services.
Why Does Independence Matter?
Separating clinical monitoring from site operations allows monitoring teams to assess study activities without being directly involved in their day-to-day delivery.
This helps maintain objectivity when reviewing clinical trial data, assessing protocol compliance and identifying potential risks to participant safety.
Independent reporting lines also allow findings to be escalated separately from site management, helping maintain objectivity and giving sponsors greater visibility of how their studies are conducted.
How Independent Monitoring Works at MAC
At MAC, our dedicated clinical monitoring team is made up of Clinical Trial Managers, Clinical Research Associates (CRAs) and Clinical Trial Administrators.
As a full-service CRO with a fully-owned network of UK investigator sites, alongside the ability to work with external sites worldwide, maintaining a clear separation between site management and clinical monitoring is an important part of our approach.
Our CRAs work independently from Site Management Organisation teams across both MAC-owned and external research sites, with separate working areas, distinct standard operating procedures and reporting lines outside of Clinical Research Services.
This structure allows our monitoring team to review site activities objectively, without being directly involved in the day-to-day operations of the sites they oversee.
Monitoring activities include source data verification, reviewing protocol deviations, following up on corrective and preventive actions and escalating findings where necessary.
Supporting Quality and Compliance
Our clinical monitoring team is also supported by MAC’s independent Quality Assurance department, providing a further level of oversight.
This helps support compliance with Good Clinical Practice and other applicable regulatory requirements, while contributing to ongoing inspection and audit readiness.
By keeping clinical monitoring separate from site operations, MAC can offer sponsors the benefits of its fully-owned research site network and wider clinical research services while maintaining independent oversight of study activities.
This separation supports participant safety, the quality and reliability of clinical trial data, and confidence in how studies are conducted.
You can find out more about MAC’s clinical monitoring capabilities and wider clinical operations services here.
